Korea identifies genetic pathway that suppresses neurodegenerative diseases

Therapeutics |  News | 0 Comment | 17 Mar, 2021

Nucleocytoplasmic transport (NCT) defects have been implicated in neurodegenerative diseases, such as C9ORF72-associated...Read more

Govt launches $15 M grant for development of innovative therapies for mental illness

Therapeutics |  News | 0 Comment | 17 Mar, 2021

The Australian government is launching a $15 million competitive grant round to kick start Australian clinical trials ex...Read more

Singapore identifies chemotherapy-resistant cancers’ escape mechanism

Therapeutics |  News | 0 Comment | 16 Mar, 2021

ETC-159, a made-in-Singapore anti-cancer drug that is currently in early phase clinical trials for use in a subset ...Read more

Fujitsu, Kyoto University build AI system to detect genetic disorders

Therapeutics |  News | 0 Comment | 15 Mar, 2021

Fujitsu Limited and Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate Scho...Read more

HSA approves first commercial CAR-T therapy by Novartis

Therapeutics |  News | 0 Comment | 10 Mar, 2021

Novartis has announced that Singapore Health Sciences Authority (HSA) has approved Kymriah (tisagenlecleucel) as th...Read more

Setsuro Tech gets access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan

Therapeutics |  News | 0 Comment | 10 Mar, 2021

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...Read more

Hong Kong unveils next-gen drug for cancers associated with Epstein–Barr virus

Therapeutics |  News | 0 Comment | 03 Mar, 2021

A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the potential to ...Read more

Australia invests $100 M for major advances in medical research technology

Therapeutics |  News | 0 Comment | 26 Feb, 2021

The Australian Government is investing $100 million into the development of new technologies to improve diagnosis and tr...Read more

Korean, Swiss firms leverage oncology expertise to initiate research collaboration

Therapeutics |  News | 0 Comment | 25 Feb, 2021

Genome & Company, a global leading immuno-oncology firm based in South Korea, and Debiopharm, a Swiss-based biopharm...Read more

Whole-genome sequencing improves diagnosis of broader range of genetic diseases

Therapeutics |  News | 0 Comment | 19 Feb, 2021

Illumina, Inc. on Feb 19, 2021 announced an agreement with the Institute of Medical Genetics and Applied Genomics at the...Read more

Taiwan reveals new findings to treat Parkinson's disease

Therapeutics |  News | 1 Comment | 19 Feb, 2021

Bened Biomedical, a leading Taiwanese probiotic company, has announced a successful clinical study for its PS128 psychob...Read more

Japan discovers potential therapeutic stem cells to cure neurodegenerative disease

Therapeutics |  News | 1 Comment | 17 Feb, 2021

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease resulting in the gradual loss of motor nerve cells (n...Read more

Bia-Echo Foundation invests $8M in Singapore to study women’s reproductive longevity

Therapeutics |  News | 0 Comment | 16 Feb, 2021

The Centre, to be established at the Yong Loo Lin School of Medicine at Singapore's National University of Singapore (NU...Read more

Singapore discovers brain enzyme that activates dormant neural stem cells

Therapeutics |  News | 0 Comment | 12 Feb, 2021

Singapore's Duke-NUS Medical School researchers studying an enzyme in fruit fly larvae have found that it plays an ...Read more

Australia invests $8 M for research into neurofibromatosis

Therapeutics |  News | 0 Comment | 11 Feb, 2021

The Australian Government is investing $8 million to support the Children’s Tumour Foundation and research into ne...Read more

Olympus supports dissemination of endoscopic procedures for Colorectal Cancer in Russia

Therapeutics |  News | 0 Comment | 09 Feb, 2021

Olympus Corporation announced on Feb 4, 2021 that it has been selected by Japan's Ministry of Health, Labour and Welfare...Read more

Japan invests in development program for skin microbiome

Therapeutics |  News | 0 Comment | 08 Feb, 2021

MyBiotics Pharma, a microbiome therapeutics company based in Israel, announced that it has received an investment from&n...Read more

Thermo Fisher, JW Therapeutics announce CAR-T partnership in China

Therapeutics |  News | 0 Comment | 04 Feb, 2021

Thermo Fisher Scientific has signed an agreement with JW Therapeutics, a leading cell therapy company, to ensure non-exc...Read more